Korean Journal of Community Nutrition (대한지역사회영양학회지)

The Korean Society of Community Nutrition (대한지역사회영양학회)
권호 표지

The Association between hs-CRP Concentration of Blood and Metabolic Syndrome in the Residents of a Rural Community

일부 농촌지역 주민들의 혈중 hs-CRP 농도와 대사증후군 위험인자와의 관계

  • Kim, Jong-Im (Department of Nursing, Daejeon Health Sciences College)
  • Received : 2010.10.21
  • Accepted : 2010.12.14
  • Published : 2010.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

This study investigated the correlations and risk distribution differences between high sensitivity C-reactive protein (hs-CRP) and the diagnosis factors of metabolic syndrome among the residents of a rural community. Two thousand adults aged from 40 to 70 were recruited and 1,968 subjects were included in the study after excluding those with infectious disease or with hs-CRP higher than 10 mg/L in blood. The subjects were then divided into three groups of hs-CRP to examine the correlations and risk ratio with the risk factors of metabolic syndrome. There was a tendency of hs-CRP increasing according to the number of risk factors of metabolic syndrome. The risk ratio with hs-CRP according to metabolic syndrome significantly increased by 2.0 and 2.2 times in the intermediate and high risk group, respectively, compared with the low risk group. The risk ratio with the risk factors of metabolic syndrome according to hs-CRP rose in abdominal obesity, triglyceride, and W/Ht in the intermediate risk group of hs-CRP. The risk ratio also surged in high pressure, W/Ht, ex-drinking (1.7 times), exsmoking (2.0 times) and current smoking (2.0 times) in the high risk group. The results indicate that hs-CRP is related to the risk factors of metabolic syndrome and that it's very important to manage obesity including abdominal obesity and W/Ht and everyday habits including drinking and smoking.

Keywords

References

  1. Ahn SK, Chun BY, Kam S, Jin DG, Kim JY (2002): Serum total cholesterol levels and related factors in a rural adult population. J Prev Med Pub Health 35(3): 256-262
  2. Aguilar D, Fisher MR, O'Connor CM, Dunne MW, Muhlestein JB, Yao L, Gupta S, Benner RJ, Cook TD, Edwards D, Pfeffer MA (2006): Metabolic syndrome, C-reactive protein, and prognosis in patients with established coronary artery disease. Am Heart J 152: 298-304. https://doi.org/10.1016/j.ahj.2005.11.011
  3. Albert MA (2000): The role of C-reactive protein in cardiovascular disease risk. Curr Cardiol Rep 2(4): 274-279 https://doi.org/10.1007/s11886-000-0081-7
  4. Berenson GS, Srinivasan SR, Bao W, Newman WP, Tracy RE, Wattigney WA (1998): Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med 338(23): 1650-1656 https://doi.org/10.1056/NEJM199806043382302
  5. Blake GJ, Ricker PM (2003): C-reactive protein and other inflammatory risk markers in acute coronary syndrome. J Am College Cardiology 41(4): 37-42 https://doi.org/10.1016/S0735-1097(02)02953-4
  6. Castelli WP (1998): Cholesterol and lipids in the risk of coronary heart disease: The framingham heart study. Can J Cardiol 4: 5A-10A
  7. Facchini F, Chen YD, Reaven GM (1994): Light-to-moderate alcohol intake is associated with enhanced insulin sensitivity. Diabetes Care 17(2): 115-119 https://doi.org/10.2337/diacare.17.2.115
  8. Ford ES, Galuska DA, Gillespie C, Will JC, Giles WH, Dietz WH (2001): C-reactive protein and body mass index in children; findings from the national health and nutrition examination survery. 1998-1994. J Pediatr 138(4): 486-492 https://doi.org/10.1067/mpd.2001.112898
  9. Freeman DJ, Norrie J, Caslake MJ, Gaw A, Ford I, Lowe GD, O'Reilly DS, Packard CJ, Sattar N (2002): C-Reactive protein is an independent predictor of risk for the development of diabetes in the west of scotland coronary prevention study. Diabetes 51(5): 1596-1600 https://doi.org/10.2337/diabetes.51.5.1596
  10. Frohlich M, Imhof A, Berg G, Hutchinson WL, Pepys MB, Boeing H, Muche R, Brenner H, Koenig W (2000): Association between C-reactive protein and features of the metabolic syndrome: a population-based study. Diabetes Care 23(12): 1835-1839 https://doi.org/10.2337/diacare.23.12.1835
  11. Grundy SM, Cleeman JL, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC, Spertus JA, Costa F (2005): American heart association; national heart, lung, and blood institute, diagnosis and management of the metabolic syndrome: an American heart association/national heart, lung, and blood institude scientific statement. Circulation 112: 2735-2752 https://doi.org/10.1161/CIRCULATIONAHA.105.169404
  12. Hsieh SD, Muto T (2006): Metabolic syndrome in Japanese men and women with special reference to the anthropometric criteria for the assessment of obesity: Proposal to use the waist-to-height ratio. Prev Med 42(2): 135-139 https://doi.org/10.1016/j.ypmed.2005.08.007
  13. Isomaa P, Almaren P, Tuomi T, Forsen B, Lahti K, Nissen M (2001): Cardiovascular morbidity and associated with the metabolic syndrome. Diabetes Care 24(4): 683-689 https://doi.org/10.2337/diacare.24.4.683
  14. JNC (2003): The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
  15. KIMS POC (Point of Care) (2007): Current data of HDL in Korean and new proposal to define role of HDL in Korean. Available from http://www.kimsonline.co.kr
  16. KOSSO (2005): Korean Society for the Study of Obesity
  17. Kwon HS, Park YM, Lee HJ, Lee JH, Choi YH, Ko SH, Lee JM, Kim SR, Kang SY, Lee WC, Ah MS (2005): The prevalence and clinical characteristics of the metabolic syndrome in middleaged Korean adults. Korean J Med 68(4): 359-369
  18. Lim S, Lee HK, Kim KC, Park C, Shin C, Cho NH (2006): Submitted to journal of endocrinological investigation a ruralurban comparison of the characteristics of metabolic syndrome by gender in Korea: The Korea Health and Denome Study (KHGS). J Endocrinol Invest 29(4): 303-319
  19. Marroquin OC, Kip KE, Kelley DE, Johnson BD, shaw LJ, Bairey Merz CN, Sharaf BL, Pepine CJ, Sopko G, Reis SE (2004): Metabolic syndrome modifies the cardiovascular risk associated with angiographic coronary artery disease in women: A report from the women's ischemia syndrome evaluation. Circulation 109(6): 714-721 https://doi.org/10.1161/01.CIR.0000115517.26897.A7
  20. McNeill AM, Rosamond WD, Girman CK, Golden SH, Schmidt ML, East HE, Rhys Williams G (2005): The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diabetes Care 28(2): 385-390 https://doi.org/10.2337/diacare.28.2.385
  21. Meshkani R, Taghikhani M, Larijani B, Khatami B, Khatami S, Khoshbin E, Adeli K (2006): The relationship between homeostasis model assessment and cardiovascular risk factors in Iranian subjects with normal fasting glucose and normal glucose tolerance. Clin Chim Acta 371(2): 169-175 https://doi.org/10.1016/j.cca.2006.03.018
  22. Nakanishi N, shirishi T, Wada M (2005): Association between fasting glucose and C-reactive protein in a Japanese population: the Minoh study. Diabetes Research and Clinical Practice 69(1): 88-98 https://doi.org/10.1016/j.diabres.2004.11.009
  23. Park JS, Park HD, Yun JW, Jung CH, Lee WY, Kim SW (2002): Prevalence of the metabolic syndrome as defined by NCEP-APT among the urban Korean population. Korean J Med 63(3): 290-298
  24. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO, Criqui M (2003): Markers of inflamation and cardiovascular disease: Application to clinical and public health practice: A statement for healthcare professionals from the centers for disease control and prevention and the American heart association. Circulation 107(3): 499-511 https://doi.org/10.1161/01.CIR.0000052939.59093.45
  25. Reaven GM (1998): Role of insulin resistance in human disease. Diabetes 37(12): 1595-1607
  26. Roberts WL (2004): CDC/AHA wirkshop on marlers of inflammation and cardiovascular disease: Application to clinical and public health practice: laboratory tests available to assess inflammation-performance and standardization. Circulation 110(25): 572-576 https://doi.org/10.1161/01.CIR.0000148986.52696.07
  27. Ridker PM, Stampfer MJ, Rifai N (2001): Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA 285(19): 2481-2485 https://doi.org/10.1001/jama.285.19.2481
  28. Ridker PM, Buring JE, Cook NR, Rifai N (2003): C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation 107(3): 391-397 https://doi.org/10.1161/01.CIR.0000055014.62083.05
  29. Ridker PM, Wilson PW, Grundy SM (2004): Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk? Circulation 109(23): 2818-2825 https://doi.org/10.1161/01.CIR.0000132467.45278.59
  30. Solymoss BC, Bourassa MG, Campeau L, Sniderman A, Marcil M, Lesperance J, Levesque S, Varga S (2004): Effect of increasing metabolic syndrome score on atherosclerotic risk profil and coronary artery disease angiographic severity. Am J Cardiol 93(2): 159-164 https://doi.org/10.1016/j.amjcard.2003.09.032
  31. Sower JR (2003): Obesity as a cardiovascular risk factors. Am J Med 115(8A): 37-44
  32. Stern MP, Williams K, Haffer SM (2002): Identification of persons at high risk for type 2 diabetes mellitus: Do we need the oral glucose tolerance test? Ann Inter Med 136(8): 575-581 https://doi.org/10.7326/0003-4819-136-8-200204160-00006
  33. Tracy RP, Lemaitre RN, Psaty BM, Lves DG, Evans RW, Cushman M, Meilahn EN, Kuller LH (1997): Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project. Arterioscler Thromb Vasc Biol 17(6): 1121-1127 https://doi.org/10.1161/01.ATV.17.6.1121
  34. Wamala SP, Lynch J, horsten M, Mittleman MA, Schench-Gustafsson K, Orth-Gomer K (1999): Education and the metabolic syndrome in women. Diabetes Care 22(12): 1999-2003 https://doi.org/10.2337/diacare.22.12.1999
  35. WHO WPR (2000): The Asia-Pacific perspective: Redefining obesity and its treatment, Sydney, Australia, World Health Organization Western Pacific Region